AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARROW, INC. Director's Dealing 2023

Jun 23, 2023

31774_dirs_2023-06-23_3053703a-13d1-419f-bc1e-ffcce3b5354f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2023-06-21

Reporting Person: Van Horn R. Lawrence (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-21	RSU	$0	A	7744	Acquired		Common Stock (7744)	Direct

Footnotes

F1: The Restricted Stock Units were received as a compensatory award for no consideration.

F2: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.